TENAX THERAPEUTICS, INC. Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature
TENAX THERAPEUTICS, INC. (TENX) reported Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature of $3.29 million for the 551-month period ending 2013-04-30, per its 10-K filed 2013-06-26.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature · last filed 2013-06-26
- 2013-04-30: Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 551 month $3.29M.
| Period end | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature 551 month |
|---|---|
| 2013-04-30 | $3.29M 10-K · filed 2013-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |